NCT05185284 | Randomized Multicenter Study on the Efficacy and Safety of Favipiravir for Parenteral Administration Compared to Standard of Care in Hospitalized Patients With COVID-19 | |
NCT04843761 | ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19 | |
NCT04853901 | Remdesivir Efficacy In Management Of COVID-19 Patients | |
NCT04640168 | Adaptive COVID-19 Treatment Trial 4 (ACTT-4) | |
NCT04593940 | Immune Modulators for Treating COVID-19 | |
NCT04492475 | Adaptive COVID-19 Treatment Trial 3 (ACTT-3) | |
NCT04401579 | Adaptive COVID-19 Treatment Trial 2 (ACTT-2) | |
NCT04292730 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment | |
NCT04292899 | Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19) | |
NCT04280705 | Adaptive COVID-19 Treatment Trial (ACTT) | |